Multipoint Thermal Sensors Associated with Improved Oncologic Outcomes Following Cryoablation

Area of Science:

• Urology
• Minimally Invasive Surgery
• Oncology

Background:

• Cryoablation (CA) is a minimally invasive technique for small renal cortical neoplasms (RCN).
• Effective tumor destruction in CA relies on achieving specific target temperatures.
• Precise temperature monitoring is crucial for successful CA outcomes.

Purpose of the Study:

• To investigate the long-term oncologic outcomes of CA for small renal tumors.
• To evaluate the impact of multipoint thermal sensors (MTS) on CA efficacy.
• To determine if real-time temperature monitoring improves recurrence-free survival.

Main Methods:

• Retrospective review of 20 patients with RCN treated with CA between 2005-2009.
• Comparison of outcomes between 11 procedures using MTS and 9 procedures without MTS.
• Follow-up imaging (CT or MRI) to assess tumor recurrence status.

Main Results:

• No recurrence was observed in the MTS group (n=11) versus 44.4% recurrence in the non-MTS group (n=9) after a mean follow-up of 45 months (p=0.026).
• Biopsy-confirmed renal cancers showed no recurrence in the MTS group (n=6) compared to 50% in the non-MTS group (n=6) (p=0.182).
• MTS use was associated with increased freeze duration, procedure time, and cryoprobe utilization.

Conclusions:

• Multipoint thermal sensors (MTS) significantly improve oncologic outcomes in cryoablation for small renal masses.
• Real-time temperature monitoring with MTS enhances the effectiveness of CA by ensuring adequate tumor ablation.
• MTS technology represents a valuable tool for optimizing CA procedures and reducing recurrence rates.